Plasma BNP and NT-proBNP are also used clinically to guide the management of patients with HF and cardiac dysfunction, and they are also used as prognostic indicators which can help clinicians adjust their therapy strategy and determine therapy effectiveness to improve a patient’s survival [40,79]. The gene discussed is NPPB; the disease is hydrops fetalis.